Published in Cardiovascular Business Week, May 15th, 2007
Over the years, researchers have experimented with adding additional risk factors to the formula to try to narrow the grey zone of mid-range results. Now, after testing three dozen separate risk factors, Harvard researchers have found that adding just two --a measurement of C-reactive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.